Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Discover some prominent but rare aircraft, which small fleets has played vital roles.

Discover when to visit primary care, urgent care, or the ER, and make the smart choice for your symptoms and budget today.

New data reveals faster than ever hospital stroke response times, yet more to be done Key points The Australian Stroke Clinical Registry (AuSCR), run ...

Azurity Pharmaceuticals, Inc. announced that ARYNTA(TM) (lisdexamfetamine dimesylate) Oral Solution is now available in the United States for treating ADHD in adults and pediatric patients 6 years and ...

The rise in popularity of IV drips is fueled by promises of increased wellbeing, despite official warnings about the health ...

A new Chronicle data tool makes it easier to review nursing home violations - knowing how to interpret them is key to making ...

Every three to five years, Puerto Rico, a territory of the United States in the Caribbean, experiences epidemic levels of ...

“Azurity Pharmaceuticals is proud to offer Arynta as an option for patients who need or prefer an oral liquid and are seeking flexibility in their treatment options,” said Ronald Scarboro, CEO of ...

New drugs, enhanced treatment approaches and a better understanding of root causes may help to slow down or stop the disease ...

AI is not overhyped. The potential requires equal attention to the less glamorous but more important role of data management.